How TauroLock™ can maintain your vascular access lines The TauroLock™ portfolio has been trusted for over 20 years to reduce vascular catheter infections, biofilm, and occlusions.

Biofilm Eradication and Prevention Taurolidine the key ingredient of TauroLock™ has demonstrated the ability to eradicate biofilm¹ and helps prevent biofilm formation within the catheter lumen.^¹

Infection Prevention TauroLock™ ‘can reduce the risk of catheter infection approximately fourfold when used prophylactically.’ ¹ It has been shown to be active against both Gram-positive and Gram-negative bacteria. It also exhibits antifungal activity, offering broad- spectrum antimicrobial protection.^¹

Occlusion Prevention TauroLock™-U25.000 incorporates taurolidine, citrate, and urokinase to prevent clotting, with weekly use reducing catheter exchanges and thrombolysis.²

By integrating antimicrobial and anti-occlusive properties into a single solution, TauroLock™ supports a proactive, prevention-focused approach to vascular access management.

1. Piątkowska, E., et al. (2021). Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties. PLOS ONE, 16(10), p.e0258148. doi:https://doi.org/10.1371/journal.pone.0258148

2. Al-Ali, F., et al. (2017). Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Nephrology Dialysis Transplantation, 33(4), pp.619–626. doi:https://doi.org/10.1093/ndt/gfx187.